Optum quietly buys New York physician group

Optum has purchased Middletown, N.Y.-based Crystal Run Healthcare, a multispecialty physician group with over 400 providers across more than 30 locations.

Advertisement

The deal was made official Feb. 22, according to a letter from Crystal Run CEO Hal Teitelbaum, MD, to employees obtained by Mid-Hudson News. The purchase was not publicly announced by Optum or Crystal Run.

“We will join Optum as part of their Tri-State Team, and will no longer have physician owners,” Dr. Teitelbaum wrote. “Crystal Run has long recognized that the fee-for-service reimbursement model is broken, and we committed to transition to value-based care focused on the quadruple aim.”

Crystal Run provides care across nearly 50 specialties in the Hudson Valley and lower Catskill region of New York. Its ambulatory surgery center offers gastroenterology, orthopedic, pain management, otolaryngology, gynecology, urology, plastic and reconstructive surgery, ophthalmology, and general surgery services, according to its website

In February, Optum closed on a $5.4 billion acquisition of LHC Group, a home health company with 30,000 employees across 38 states. In 2022, Optum purchased at least five other provider groups. In total, the company employs or is affiliated with 70,000 physicians nationwide across 2,200 locations.

At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.

Register to Attend Webinar

Read. Deleted. Ignored. What It Takes to Drive Behavior Change and Lower the Cost of Care

Tuesday, August 4
11:00 AM - 12:00 PM CDT

Presenters: Koleen Cavanaugh, Independence Blue CrossBukata Hayes, HMO Minnesota (Blue Plus)Nathan Foco, Select HealthTrish Cox, SCAN Health PlanJonas Puente, ZS Associates

Advertisement

Next Up in M&A

Advertisement

Comments are closed.